PSC Biotech becomes De Lama’s exclusive distributor in four markets

By AI, Created 5:47 AM UTC, May 28, 2026, /AGP/ – PSC Biotech said May 28, 2026, that it will serve as De Lama’s exclusive distributor and local service provider for the life sciences industry in the U.S., Canada, Singapore and Australia. The deal pairs De Lama’s sterilization systems with PSC Biotech’s validation and compliance services, aiming to make advanced equipment easier to deploy in regulated GMP settings.

Why it matters: - The partnership gives life science companies in four major markets a single channel for advanced sterilization equipment and local implementation support. - The deal is meant to close the gap between equipment purchase and GMP-ready deployment, which can affect validation speed, compliance and operational efficiency. - PSC Biotech and De Lama are positioning the combined offering for pharmaceutical, biopharmaceutical and laboratory customers that need validated sterilization outcomes.

What happened: - PSC Biotech announced May 28, 2026, that it has been named De Lama’s exclusive distributor and local service provider across the life sciences industry in the United States, Canada, Singapore and Australia. - The partnership covers De Lama’s sterilization, washing and decontamination portfolio. - The announcement was made from Pomona, California.

The details: - De Lama’s portfolio includes the MagnetoDoor®, HyPerPure® vH202 sterilizer, ZeroStop® sterilization tunnel and combo process systems such as washer-sterilizers and a vH202-saturated steam combined sterilizer. - De Lama’s systems are designed to support cleaning and decontamination through terminal sterilization of components and finished products. - The companies said the systems are intended to deliver consistent, validated sterilization outcomes while protecting sensitive materials. - The equipment is also meant to reduce cycle times and improve operational efficiency. - PSC Biotech brings pharmaceutical consulting, validation and compliance expertise to the arrangement. - The combined model is intended to support equipment selection, qualification and maintenance in regulated GMP environments. - PSC Biotech cited stronger local support as part of the value for life science customers. - Alfonso Fasano, director of new technologies and partnerships at PSC Biotech, said the partnership aligns with PSC Biotech’s goal of bringing advanced equipment to the life sciences market. - Fasano also said the combination of De Lama’s cGMP-compliant manufacturing and PSC Biotech’s validation capabilities, market presence and customer support should help deliver compliant, high-performing process solutions. - Marco Bianchi, owner and marketing and sales manager at De Lama, and Guido Rovera, sales and marketing director at De Lama, said De Lama had been looking for the right partner for years before choosing PSC Biotech. - Bianchi and Rovera said PSC Biotech’s U.S. footprint and expertise in technical service, software, compliance and customer support were key factors in the decision. - De Lama said the partnership should give American pharmaceutical companies easier access to its sterilization, washing and decontamination technologies. - De Lama highlighted HyPerPure® for deep-vacuum vaporized hydrogen peroxide sterilization, Magnetodoor® for isolator integration and ZeroStop® for continuous sterilization.

Between the lines: - The announcement signals a distribution model that mixes hardware access with services needed to make regulated equipment usable in practice. - PSC Biotech is broadening beyond consulting and software into a more direct role in equipment distribution and local service. - De Lama is using the partnership to expand its reach in the U.S. market through a partner with established regional coverage.

What’s next: - The companies are set to roll out the partnership in the four named markets and support customer adoption of De Lama’s systems. - Life science companies in those regions can expect access to De Lama equipment through PSC Biotech, along with local support for qualification and maintenance. - More information is available through PSC Biotech’s website, PSC Software, BioTechnique, De Lama’s website, and PSC Biotech’s LinkedIn page.

The bottom line: - PSC Biotech and De Lama are pairing sterilization technology with compliance and service support to make regulated deployment faster and more practical for life science customers.